Term Name: | alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc |
---|---|
Synonyms: | 2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-galactopyranose, 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-2-deoxy-beta-D-galactopyranose, 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranose, 2-acetamido-3-O-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-2-deoxy-beta-D-galactopyranose, alpha-D-GalNAc-(1->3)-beta-D-GalNAc, alphaGalNAc(1->3)betaGalNAc, beta-D-galactopyranose, 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-2-deoxy-, FORSMANN ANTIGEN, Forssman disaccharide, GalNAca1-3GalNAcb, N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosamine, WURCS=2.0/2,2,1/[a2112h-1b_1-5_2*NCC/3=O][a2112h-1a_1-5_2*NCC/3=O]/1-2/a3-b1 |
Definition: | An alpha-D-GalpNAc-(1->3)-D-GalpNAc having beta-configuration at the reducing end anomeric centre. |
Ontology: | ChEBI [CHEBI:42528] ( EBI ) |